Company intelligence / Profile preview

M.M.A. Tech

Ownership: Private
Employees: ~8
Development stage: Other

Overview

M.M.A. Tech has developed a novel acetabular liner made from Polyimide MP1™, designed to address wear, bone resorption, and implant shifting issues common with traditional polyethylene liners in hip replacements. The product has received CE approval and is ISO 13485 certified. Clinical studies are ongoing in New Zealand (100 patients) and Israel (15 patients), with the latter registered on ClinicalTrials.gov as NCT02503891 to support future FDA approval.

Therapeutic areas: RheumatologyOther
Modalities: Polymer-based medical deviceBiocompatible polymer (Polyimide MP1™)
Industry: Implantable Medical Devices

Partnerships

Contract with a leading orthopedic company in Europe for distribution or development collaboration

Beyond the preview

Go deeper on M.M.A. Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M.M.A. Tech.

Explore the full profile